These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8402683

  • 1. Human cytotoxic T-cells suppress the growth of spontaneous melanoma metastases in SCID/hu mice.
    Sabzevari H, Reisfeld RA.
    Cancer Res; 1993 Oct 15; 53(20):4933-7. PubMed ID: 8402683
    [Abstract] [Full Text] [Related]

  • 2. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F, Abe M, Akiyoshi T, Nomura T, Sugimachi K, Kishimoto T, Suzuki T, Okada M.
    Cancer Res; 1997 Apr 01; 57(7):1335-43. PubMed ID: 9102222
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of human natural killer cells on the metastatic growth of human melanoma xenografts in mice with severe combined immunodeficiency.
    Hill LL, Perussia B, McCue PA, Korngold R.
    Cancer Res; 1994 Feb 01; 54(3):763-70. PubMed ID: 8306339
    [Abstract] [Full Text] [Related]

  • 6. Differential effect of high doses versus low doses of interleukin-12 on the adoptive transfer of human specific cytotoxic T lymphocyte in autologous lung tumors engrafted into severe combined immunodeficiency disease-nonobese diabetic mice: relation with interleukin-10 induction.
    Asselin-Paturel C, Megherat S, Vergnon I, Echchakir H, Dorothée G, Blesson S, Gay F, Mami-Chouaib F, Chouaib S.
    Cancer; 2001 Jan 01; 91(1):113-22. PubMed ID: 11148567
    [Abstract] [Full Text] [Related]

  • 7. IL-2 gene-transduced human HLA-A2 melanoma cells can generate a specific antitumor cytotoxic T-lymphocyte response.
    Guarini A, Gansbacher B, Cronin K, Fierro MT, Foa R.
    Cytokines Mol Ther; 1995 Mar 01; 1(1):57-64. PubMed ID: 9384664
    [Abstract] [Full Text] [Related]

  • 8. Cloned human CD8+ cytotoxic T lymphocytes protect human peripheral blood leukocyte-severe combined immunodeficient mice from HIV-1 infection by an HLA-unrestricted mechanism.
    van Kuyk R, Torbett BE, Gulizia RJ, Leath S, Mosier DE, Koenig S.
    J Immunol; 1994 Nov 15; 153(10):4826-33. PubMed ID: 7963548
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adoptive transfer of an anti-MART-1(27-35)-specific CD8+ T cell clone leads to immunoselection of human melanoma antigen-loss variants in SCID mice.
    Lozupone F, Rivoltini L, Luciani F, Venditti M, Lugini L, Cova A, Squarcina P, Parmiani G, Belardelli F, Fais S.
    Eur J Immunol; 2003 Feb 15; 33(2):556-66. PubMed ID: 12645955
    [Abstract] [Full Text] [Related]

  • 11. Involvement of B lymphocytes in the growth inhibition of human pulmonary melanoma metastases in athymic nu/nu mice by an antibody-lymphotoxin fusion protein.
    Reisfeld RA, Gillies SD, Mendelsohn J, Varki NM, Becker JC.
    Cancer Res; 1996 Apr 15; 56(8):1707-12. PubMed ID: 8620479
    [Abstract] [Full Text] [Related]

  • 12. Autologous high-killing cytotoxic T lymphocytes against human lung cancer are induced using interleukin (IL)-1beta, IL-2, IL-4, and IL-6: possible involvement of dendritic cells.
    Saijo Y, Hong X, Tanaka M, Tazawa R, Liu SQ, Saijo K, Ohno T, Koike K, Ohkuda K, Satoh K, Nukiwa T.
    Clin Cancer Res; 1999 May 15; 5(5):1203-9. PubMed ID: 10353758
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An in vivo model of priming of antigen-specific human CTL by Mo-DC in NOD/Shi-scid IL2rgamma(null) (NOG) mice.
    Inoue M, Senju S, Hirata S, Irie A, Baba H, Nishimura Y.
    Immunol Lett; 2009 Sep 22; 126(1-2):67-72. PubMed ID: 19682495
    [Abstract] [Full Text] [Related]

  • 15. Small cell lung carcinomas express shared and private tumor antigens presented by HLA-A1 or HLA-A2.
    Yamazaki K, Spruill G, Rhoderick J, Spielman J, Savaraj N, Podack ER.
    Cancer Res; 1999 Sep 15; 59(18):4642-50. PubMed ID: 10493519
    [Abstract] [Full Text] [Related]

  • 16. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G.
    Br J Cancer; 2001 Nov 30; 85(11):1722-30. PubMed ID: 11742494
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification of a novel tumor-associated antigen, cadherin 3/P-cadherin, as a possible target for immunotherapy of pancreatic, gastric, and colorectal cancers.
    Imai K, Hirata S, Irie A, Senju S, Ikuta Y, Yokomine K, Harao M, Inoue M, Tsunoda T, Nakatsuru S, Nakagawa H, Nakamura Y, Baba H, Nishimura Y.
    Clin Cancer Res; 2008 Oct 15; 14(20):6487-95. PubMed ID: 18927288
    [Abstract] [Full Text] [Related]

  • 19. Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiency.
    Taylor CW, Grogan TM, Lopez MH, Leong SP, Odeleye A, Feo-Zuppardi FJ, Hersh EM.
    Lab Invest; 1992 Jul 15; 67(1):130-7. PubMed ID: 1625443
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.